EQT Private Equity to sell Schülke, a sustainability leader in infection prevention and treatment for the healthcare industry - Seite 2

Central to EQT Private Equity and Schülke's partnership has been the delivery of a customer centric sustainability strategy. Through a strategic approach to sustainability, the Company established a pioneering green hospital-grade product line, transitioned to almost 100% green electricity, and signed up to the Science Based Targets initiative, with the target to reduce greenhouse gas emissions by up to 40% by 2030. Through this transformation, Schülke has positioned itself as a key partner to its healthcare and life sciences clients in their efforts to make the industry more sustainable. 

Matthias Wittkowski, Partner within EQT Private Equity's Advisory Team, said: "We were excited about Schülke's purpose and mission critical role in the healthcare industry when we acquired the business, and are even more so today. In close partnership with the management team, we have transformed Schülke from a corporate subsidiary to a high-performing, stand-alone healthcare company. We are proud to have supported the Company in becoming a sustainability leader that today fully lives up to its mission of "protecting lives worldwide". This again showcases EQT Private Equity's ability to carve out high-potential companies, drive transformation and position them for long-term success. We believe that the ATHOS Consortium is a fantastic partner for Schülke as it takes the next step on its journey." 

Stefan Kukacka, CEO of Schülke, said: "It has been a pleasure working with EQT Private Equity over the past years. Together we have strategically re-positioned the business, driven organic growth, and pursued an active M&A agenda with five add-on acquisitions. Perhaps most importantly, we delivered on a sustainability transformation strategy to ensure that we live up to our mission and are set up for sustainable growth. We are grateful for the partnership and are now looking forward to building on this momentum under the ownership of the ATHOS Consortium." 

The transaction is subject to customary regulatory approvals. It is expected to close in Q4 2023. 

EQT Private Equity was advised by Bank of America, Freshfields Bruckhaus Deringer, Deloitte and Bain & Company. 

Contact 
EQT Press Office,
[e-mail],
[phone] 

The following files are available for download:

https://mb.cision.com/Main/87/3814127/2216710.pdf	PR_EQT Private Equity to sell Schuelke_230807
https://news.cision.com/eqt/i/schuelke,c3203683	Schuelke

 

View original content:https://www.prnewswire.co.uk/news-releases/eqt-private-equity-to-sell-schulke-a-sustainability-leader-in-infection-prevention-and-treatment-for-the-healthcare-industry-301894366.html